Where do Syndax Pharmaceuticals's ratios come from?

Every ratio is computed from Syndax Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	-102.8%+55.4pp	-158.2%+117pp	-275.1%+159pp	-433.7%+353pp	-786.6%—
Net margin	-111.9%+53.5pp	-165.4%+114pp	-279.3%+149pp	-428.5%+329pp	-757.5%—
Returns
Return on equity	-189.5%-27.7pp	-161.8%-32.5pp	-129.3%-16.1pp	-113.2%-19.5pp	-93.7%-18.0pp
Return on invested capital	-67.9%-17.6pp	-50.3%+59.3pp	-109.6%-14.0pp	-95.5%-6.9pp	-88.6%-24.9pp
Efficiency
Asset turnover	0.4×+0.1×	0.3×0.0×	0.2×+0.1×	0.1×+0.1×	0.1×0.0×
Liquidity
Current ratio	5.5×+1.1×	4.4×-0.2×	4.6×-0.1×	4.7×-1.1×	5.8×0.0×
Leverage
Debt-to-equity	8.4×+3.0×	5.4×+2.6×	2.8×+0.7×	2.1×+0.5×	1.6×-0.8×
Per Share
Book value per share	$0.47-36.8%	$0.75-44.0%	$1.33-26.9%	$1.82-26.9%	$2.50-25.8%
Valuation
Market capitalization	$2.06B+12.8%	$1.83B+37.8%	$1.33B+67.0%	$793.36M-24.9%	$1.06B-6.3%
Price / sales	9.5×-1.1×	10.6×-1.3×	11.9×+1.7×	10.1×-14.0×	24.2×—
Price / book	49.5×+21.2×	28.3×+16.8×	11.5×+6.4×	5×+0.1×	4.9×+1.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Syndax Pharmaceuticals's ratios come from?: Every ratio is computed from Syndax Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.